Search

Author/Creator Margot, Nicolas A

1. 1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results. (15th December 2022)

Authors:
Ogbuagu, Onyema; Segal-Maurer, Sorana; Ratanasuwan, Winai; Trottier, Benoit; Brunetta, Jason; Shirasaka, Takuma; Koenig, Ellen L; Wang, Hui; Margot, Nicolas A; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared; Molina, Jean-Michel
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir. (9th September 2022)

Authors:
Margot, Nicolas A; Naik, Vidula; VanderVeen, Laurie; Anoshchenko, Olena; Singh, Renu; Dvory-Sobol, Hadas; Rhee, Martin S; Callebaut, Christian
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 11(2022)
Page Start:
1985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗